1. MiR-451 inhibits cell growth and invasion by targeting CXCL16 and is associated with prognosis of osteosarcoma patients
    Fei Zhang et al, 2015, Tumor Biol. CrossRef
  2. Blockade of CXCR6 reduces invasive potential of gastric cancer cells through inhibition of AKT signaling
    Ya Li et al, 2015, Int J Immunopathol Pharmacol CrossRef
  3. Matrix metalloproteinase-1-mediated mesenchymal stem cell tumor tropism is dependent on crosstalk with stromal derived growth factor 1/C-X-C chemokine receptor 4 axis
    Ivy A. W. Ho et al, 2014, The FASEB Journal CrossRef
  4. The Chemokine Receptor CXCR6 Evokes Reverse Signaling via the Transmembrane Chemokine CXCL16
    Vivian Adamski et al, 2017, IJMS CrossRef
  5. Human Monocyte Heterogeneity as Revealed by High-Dimensional Mass Cytometry
    Anouk A.J. Hamers et al, 2019, Arterioscler Thromb Vasc Biol. CrossRef
  6. The chemokine CXCL16 modulates neurotransmitter release in hippocampal CA1 area
    Maria Amalia Di Castro et al, 2016, Sci Rep CrossRef
  7. null
    H. Maximilian Mehdorn, 2016 CrossRef
  8. Microglia–blood vessel interactions: a double-edged sword in brain pathologies
    Nevenka Dudvarski Stankovic et al, 2016, Acta Neuropathol CrossRef
  9. “Inverse signaling” of the transmembrane chemokine CXCL16 contributes to proliferative and anti-apoptotic effects in cultured human meningioma cells
    Kirsten Hattermann et al, 2016, Cell Commun Signal CrossRef
  10. Down regulation of Akirin-2 increases chemosensitivity in human glioblastomas more efficiently than Twist-1
    Sebastian Krossa et al, 2015, Oncotarget CrossRef
  11. The Role of CXCL16 in the Pathogenesis of Cancer and Other Diseases
    Jan Korbecki et al, 2021, IJMS CrossRef
  12. CXC chemokine ligand 16: a Swiss army knife chemokine in cancer
    Arezoo Gowhari Shabgah et al, 2021, Expert Rev. Mol. Med. CrossRef
  13. Meningioma–Brain Crosstalk: A Scoping Review
    Josefine de Stricker Borch et al, 2021, Cancers CrossRef
  14. Synthesizing Molecular and Immune Characteristics to Move Beyond WHO Grade in Meningiomas: A Focused Review
    Nivedha V. Kannapadi et al, 2022, Front. Oncol. CrossRef
  15. Gene expression analysis during progression of malignant meningioma compared to benign meningioma
    Andrea D. Maier et al, 2022 CrossRef
  16. Single-cell RNA transcriptome analysis of CNS immune cells reveals CXCL16/CXCR6 as maintenance factors for tissue-resident T cells that drive synapse elimination
    Sarah F. Rosen et al, 2022, Genome Med CrossRef
  17. Structure and Function of Ligand CX3CL1 and its Receptor CX3CR1 in Cancer
    Xinjie Lu, 2022, CMC CrossRef
  18. The Tumor Immune Microenvironment in Primary CNS Neoplasms: A Review of Current Knowledge and Therapeutic Approaches
    Anita L. Kalluri et al, 2023, IJMS CrossRef
  19. null
    Gholamreza Azizi et al, 2024 CrossRef